Taosheng Chen Selected Research

Taosheng Chen Research Topics

Disease

41	Neoplasms (Cancer) 07/2024 - 05/2009
7	Leukemia 10/2023 - 11/2017
7	Alveolar Rhabdomyosarcoma 01/2022 - 11/2009
5	Hearing Loss (Hearing Impairment) 05/2024 - 01/2016
5	Neuroblastoma 03/2024 - 01/2017
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2023 - 09/2015
5	Carcinoma (Carcinomatosis) 01/2017 - 11/2008
4	Carcinogenesis 01/2022 - 04/2014
4	Neoplasm Metastasis (Metastasis) 11/2013 - 02/2011
3	Breast Neoplasms (Breast Cancer) 02/2023 - 05/2009
3	Ototoxicity 12/2020 - 01/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 07/2024 - 01/2019
2	Inflammation (Inflammations) 05/2024 - 08/2009
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 12/2021
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 01/2022
2	Cardiotoxicity 11/2021 - 01/2021
2	Anemia 01/2021 - 01/2020
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 01/2020
2	Noise-Induced Hearing Loss (Acoustic Trauma) 12/2020 - 01/2018
2	Drug-Related Side Effects and Adverse Reactions 12/2017 - 08/2009
2	Metabolic Diseases (Metabolic Disease) 05/2015 - 07/2013
2	Colonic Neoplasms (Colon Cancer) 04/2014 - 11/2013
2	Bone Diseases (Bone Disease) 05/2009 - 08/2006
1	Adenocarcinoma 07/2024
1	Hidden Hearing Loss 05/2024
1	Human Influenza (Influenza) 05/2024
1	Osteosarcoma (Osteogenic Sarcoma) 04/2024
1	Hepatoblastoma 01/2023
1	Alzheimer Disease (Alzheimer's Disease) 10/2022
1	Cognitive Dysfunction 10/2022
1	Amyloidosis 10/2022
1	Pathologic Processes 01/2022
1	Ischemia 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Melanoma (Melanoma, Malignant) 10/2020

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 03/2024 - 05/2009
9	Transcription Factors (Transcription Factor)IBA 01/2022 - 04/2011
8	Pregnane X ReceptorIBA 01/2020 - 11/2008
7	Cytochrome P-450 CYP3AIBA 07/2024 - 11/2008
6	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2022 - 04/2014
5	EnzymesIBA 07/2024 - 08/2009
5	Cisplatin (Platino)FDA LinkGeneric 05/2024 - 01/2016
5	XenobioticsIBA 12/2017 - 04/2014
4	LigandsIBA 01/2021 - 07/2013
3	Histone DemethylasesIBA 03/2024 - 01/2017
3	kenpaulloneIBA 01/2018 - 11/2008
2	Glucose (Dextrose)FDA LinkGeneric 07/2024 - 02/2023
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023 - 01/2021
2	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2023 - 01/2023
2	Adenosine Triphosphate (ATP)IBA 02/2023 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2020 - 01/2020
2	Phosphotransferases (Kinase)IBA 12/2020 - 01/2018
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2020 - 01/2019
2	Cyclin-Dependent Kinase 2IBA 01/2018 - 11/2008
2	Protein Isoforms (Isoforms)IBA 09/2017 - 09/2016
2	LuciferasesIBA 01/2017 - 01/2013
2	Orphan Nuclear ReceptorsIBA 01/2016 - 02/2015
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2010 - 11/2008
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 07/2024
1	Phosphates (Orthophosphate)IBA 05/2024
1	Antiviral Agents (Antivirals)IBA 05/2024
1	Carrier Proteins (Binding Protein)IBA 05/2024
1	Oseltamivir (Tamiflu)FDA Link 05/2024
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2024
1	Adrenergic Agents (Adrenergic Drugs)IBA 03/2024
1	Drug CombinationsIBA 11/2023
1	tyramine-deoxysorbitolIBA 10/2023
1	Ribosomal DNA (rDNA)IBA 10/2023
1	NADP (NADPH)IBA 02/2023
1	Glutamine (L-Glutamine)FDA Link 02/2023
1	Serine (L-Serine)FDA Link 02/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2023
1	Histone-Lysine N-MethyltransferaseIBA 01/2023
1	U1 Small Nuclear RibonucleoproteinIBA 10/2022
1	Small Nuclear Ribonucleoproteins (snRNP)IBA 10/2022
1	ProteomeIBA 10/2022
1	Amyloid (Amyloid Fibrils)IBA 10/2022
1	ChromatinIBA 01/2022
1	snake venom protein C activatorIBA 12/2021
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 11/2021
1	CX 5461IBA 11/2021
1	Topoisomerase I InhibitorsIBA 11/2021
1	17- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2021
1	ElonginIBA 01/2021
1	Proteolysis Targeting ChimeraIBA 01/2021
1	nilotinib FDA Link 01/2021
1	Vincristine (Oncovin)FDA LinkGeneric 01/2021
1	Calcium-Binding ProteinsIBA 01/2021
1	dabrafenibIBA 12/2020
1	Proto-Oncogene Proteins B-rafIBA 12/2020
1	Ligases (Synthetase)IBA 10/2020
1	UbiquitinIBA 10/2020
1	AntigensIBA 10/2020

Therapy/Procedure

16	Therapeutics 01/2023 - 10/2010
12	Drug Therapy (Chemotherapy) 05/2024 - 11/2009
3	Immunotherapy 11/2021 - 01/2019
1	Combination Drug Therapy (Combination Chemotherapy) 11/2023
1	Aftercare (After-Treatment) 11/2021